Julie A Phillippi1, Benjamin R Green2, Michael A Eskay2, Mary P Kotlarczyk2, Michael R Hill3, Anne M Robertson4, Simon C Watkins5, David A Vorp6, Thomas G Gleason7. 1. Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pa; Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pa; Center for Thoracic Aortic Disease, University of Pittsburgh, Pittsburgh, Pa; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pa; Center for Vascular Remodeling and Regeneration, University of Pittsburgh, Pittsburgh, Pa. 2. Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pa. 3. Institute for Computational Engineering and Sciences, University of Texas, Austin, Tex. 4. Department of Mechanical Engineering and Materials Science, University of Pittsburgh, Pittsburgh, Pa. 5. Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pa. 6. Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pa; Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pa; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pa; Center for Vascular Remodeling and Regeneration, University of Pittsburgh, Pittsburgh, Pa. 7. Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pa; Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pa; Center for Thoracic Aortic Disease, University of Pittsburgh, Pittsburgh, Pa; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pa; Center for Vascular Remodeling and Regeneration, University of Pittsburgh, Pittsburgh, Pa. Electronic address: gleasontg@upmc.edu.
Abstract
OBJECTIVES: Patients with bicuspid aortic valves (BAV) are predisposed to developing ascending thoracic aortic aneurysms (TAA) at an earlier age than patients who develop degenerative TAAs and have a tricuspid aortic valve (TAV). The hypothesis tested is that BAV-associated aortopathy is mediated by a mechanism of matrix remodeling that is distinct from that seen in TAAs of patients with tricuspid aortic valves. METHODS: Aortic specimens were collected during ascending aortic replacement, aortic valve replacement, and heart transplants from nonaneurysmal (NA) donors and recipients. Matrix architecture of the aortic media was assessed qualitatively using multiphoton microscopy followed by quantification of collagen and elastin fiber orientation. α-Elastin was determined and matrix maturity was assessed by quantifying immature and mature collagen and lysyl oxidase (Lox) expression and activity in aortic specimens. Matrix metalloproteinase-2/9 activity was quantified in aortic smooth muscle cells. RESULTS: Elastin and collagen fibers were more highly aligned in BAV-NA and BAV-TAA cases than in TAV-TAA cases, whereas TAV-TAA cases were more disorganized than TAV-NA cases. α-Elastin content was unchanged. Immature collagen was reduced in BAV-NA and BAV-TAA cases when compared with TAV-NA and TAV-TAA cases. Mature collagen was elevated in TAV-TAA cases compared with TAV-NA and BAV-TAA cases. There was a trend toward elevated Lox gene expression and activity and matrix metalloproteinase-2/9 activity for TAV-TAA, BAV-NA, and BAV-TAA specimens. CONCLUSIONS: The highly aligned matrix architecture in patients with BAVs indicates that wall remodeling is distinct from TAV-TAA. Altered matrix architecture and reduced collagen maturity suggest that the effector molecules mediating the remodeling of TAAs are different in BAV and TAV cases.
OBJECTIVES:Patients with bicuspid aortic valves (BAV) are predisposed to developing ascending thoracic aortic aneurysms (TAA) at an earlier age than patients who develop degenerative TAAs and have a tricuspid aortic valve (TAV). The hypothesis tested is that BAV-associated aortopathy is mediated by a mechanism of matrix remodeling that is distinct from that seen in TAAs of patients with tricuspid aortic valves. METHODS: Aortic specimens were collected during ascending aortic replacement, aortic valve replacement, and heart transplants from nonaneurysmal (NA) donors and recipients. Matrix architecture of the aortic media was assessed qualitatively using multiphoton microscopy followed by quantification of collagen and elastin fiber orientation. α-Elastin was determined and matrix maturity was assessed by quantifying immature and mature collagen and lysyl oxidase (Lox) expression and activity in aortic specimens. Matrix metalloproteinase-2/9 activity was quantified in aortic smooth muscle cells. RESULTS:Elastin and collagen fibers were more highly aligned in BAV-NA and BAV-TAA cases than in TAV-TAA cases, whereas TAV-TAA cases were more disorganized than TAV-NA cases. α-Elastin content was unchanged. Immature collagen was reduced in BAV-NA and BAV-TAA cases when compared with TAV-NA and TAV-TAA cases. Mature collagen was elevated in TAV-TAA cases compared with TAV-NA and BAV-TAA cases. There was a trend toward elevated Lox gene expression and activity and matrix metalloproteinase-2/9 activity for TAV-TAA, BAV-NA, and BAV-TAA specimens. CONCLUSIONS: The highly aligned matrix architecture in patients with BAVs indicates that wall remodeling is distinct from TAV-TAA. Altered matrix architecture and reduced collagen maturity suggest that the effector molecules mediating the remodeling of TAAs are different in BAV and TAV cases.
Authors: Linda Cripe; Gregor Andelfinger; Lisa J Martin; Kerry Shooner; D Woodrow Benson Journal: J Am Coll Cardiol Date: 2004-07-07 Impact factor: 24.094
Authors: Joseph E Pichamuthu; Julie A Phillippi; Deborah A Cleary; Douglas W Chew; John Hempel; David A Vorp; Thomas G Gleason Journal: Ann Thorac Surg Date: 2013-09-07 Impact factor: 4.330
Authors: Jon Boyum; Erika K Fellinger; Joseph D Schmoker; Lucy Trombley; Kenneth McPartland; Frank P Ittleman; Alan B Howard Journal: J Thorac Cardiovasc Surg Date: 2004-03 Impact factor: 5.209
Authors: Ruth J Okamoto; Haodong Xu; Nicholas T Kouchoukos; Marc R Moon; Thoralf M Sundt Journal: J Thorac Cardiovasc Surg Date: 2003-09 Impact factor: 5.209
Authors: Paul W M Fedak; Mauro P L de Sa; Subodh Verma; Nafiseh Nili; Pedram Kazemian; Jagdish Butany; Bradley H Strauss; Richard D Weisel; Tirone E David Journal: J Thorac Cardiovasc Surg Date: 2003-09 Impact factor: 5.209
Authors: Joseph E Pichamuthu; Julie A Phillippi; Deborah A Cleary; Douglas W Chew; John Hempel; David A Vorp; Thomas G Gleason Journal: Ann Thorac Surg Date: 2013-09-07 Impact factor: 4.330
Authors: Michal Sikora; David Scheiner; Cornelia Betschart; Daniele Perucchini; José María Mateos; Anthony di Natale; Daniel Fink; Caroline Maake Journal: Int Urogynecol J Date: 2014-11-25 Impact factor: 2.894
Authors: Julie A Phillippi; Jennifer C Hill; Marie Billaud; Benjamin R Green; Mary P Kotlarczyk; Thomas G Gleason Journal: Ann Thorac Surg Date: 2017-02-06 Impact factor: 4.330
Authors: Sebastian Albinsson; Alessandro Della Corte; Azra Alajbegovic; Katarzyna K Krawczyk; Ciro Bancone; Umberto Galderisi; Marilena Cipollaro; Marisa De Feo; Amalia Forte Journal: Heart Vessels Date: 2017-01-19 Impact factor: 2.037
Authors: Alkiviadis Tsamis; Julie A Phillippi; Ryan G Koch; Salvatore Pasta; Antonio D'Amore; Simon C Watkins; William R Wagner; Thomas G Gleason; David A Vorp Journal: J Biomech Date: 2013-09-11 Impact factor: 2.712
Authors: Alkiviadis Tsamis; Julie A Phillippi; Ryan G Koch; Patrick G Chan; Jeffrey T Krawiec; Antonio D'Amore; Simon C Watkins; William R Wagner; David A Vorp; Thomas G Gleason Journal: J Thorac Cardiovasc Surg Date: 2016-02-13 Impact factor: 5.209